Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review

Denosumab, a human monoclonal antibody directed against the receptor activator of nuclear factor-κβ ligand (RANKL), is used for the treatment of patients with metastatic cancer of the bone or osteoporosis. Recent reports have demonstrated that denosumab can induce osteonecrosis of the jaw (ONJ), but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Yoshimura, Hitoshi, Ohba, Seigo, Yoshida, Hisato, Saito, Kyoko, Inui, Kazuyoshi, Yasui, Rie, Ichikawa, Dai, Aiki, Minako, Kobayashi, Junichi, Matsuda, Shinpei, Imamura, Yoshiaki, Sano, Kazuo
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494808/
https://ncbi.nlm.nih.gov/pubmed/28693144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6121
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados